- Home
- FUSB vs NRXP Comparison
FUSB vs NRXP Comparison
Compare FUSB & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FUSB
- NRXP
- Stock Information
- Founded
- FUSB 1952
- NRXP 2015
- Country
- FUSB United States
- NRXP United States
- Employees
- FUSB N/A
- NRXP N/A
- Industry
- FUSB Major Banks
- NRXP Biotechnology: Pharmaceutical Preparations
- Sector
- FUSB Finance
- NRXP Health Care
- Exchange
- FUSB Nasdaq
- NRXP Nasdaq
- Market Cap
- FUSB 72.6M
- NRXP 58.5M
- IPO Year
- FUSB N/A
- NRXP N/A
- Fundamental
- Price
- FUSB $12.96
- NRXP $2.59
- Analyst Decision
- FUSB
- NRXP Strong Buy
- Analyst Count
- FUSB 0
- NRXP 4
- Target Price
- FUSB N/A
- NRXP $28.50
- AVG Volume (30 Days)
- FUSB 2.1K
- NRXP 142.1K
- Earning Date
- FUSB 07-30-2025
- NRXP 08-13-2025
- Dividend Yield
- FUSB 2.16%
- NRXP N/A
- EPS Growth
- FUSB N/A
- NRXP N/A
- EPS
- FUSB 0.97
- NRXP N/A
- Revenue
- FUSB $36,046,000.00
- NRXP N/A
- Revenue This Year
- FUSB N/A
- NRXP N/A
- Revenue Next Year
- FUSB N/A
- NRXP $230.95
- P/E Ratio
- FUSB $13.37
- NRXP N/A
- Revenue Growth
- FUSB N/A
- NRXP N/A
- 52 Week Low
- FUSB $9.80
- NRXP $1.10
- 52 Week High
- FUSB $14.30
- NRXP $6.01
- Technical
- Relative Strength Index (RSI)
- FUSB 50.31
- NRXP 27.99
- Support Level
- FUSB $12.83
- NRXP $2.89
- Resistance Level
- FUSB $13.42
- NRXP $3.15
- Average True Range (ATR)
- FUSB 0.23
- NRXP 0.13
- MACD
- FUSB 0.01
- NRXP -0.06
- Stochastic Oscillator
- FUSB 43.21
- NRXP 4.55
About FUSB First US Bancshares Inc.
First US Bancshares Inc is a bank holding company. The Bank conducts general commercial banking business and offers banking services such as demand, savings, individual retirement account and time deposits, personal and commercial loans, safe deposit box services, and remote deposit capture. The Bank provides a range of commercial banking services to small and medium-sized businesses, property managers, business executives, professionals, and other individuals.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.